Rare disease at ASGCT 2027

May 3–7, 2027 Philadelphia, PA ~8k attendees Website

3 organizations at ASGCT 2027 present work in rare disease: 2 contract manufacturers, CROs and testing labs and 1 therapy developer. 3 of them have their own page in this guide. As of Oct 29, 2026.

All 120 organizations at ASGCT 2027 →

Showing 1–3 of 3 organizations
OrganizationASGCT 2027 Attendance
Gene and cell therapy developers
Gene therapy developer and Bayer subsidiary building AAV treatments for Parkinson's disease, heart failure and other rare and common conditions.
Booth
Exhibiting at Booth 422
Propria
Branford, CT
Preclinical and discovery CROs
Preclinical CRO testing therapies for inherited heart disease on engineered cardiac tissues made from human iPSC-derived heart muscle cells.
Booth
Exhibiting at Booth 1512
PsychoGenics
Paramus, NJ
Preclinical and discovery CROs
Preclinical CRO for brain and rare disorders, offering validated mouse models, behavioral testing, EEG, electrophysiology and histology to measure treatment efficacy.
Booth
Exhibiting at Booth 1017

Explore the full ASGCT 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full ASGCT 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in rare disease

Tell us what you sell and we’ll find the people at organizations working on rare disease most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ASGCT 2027 by

Exhibit hall

Not affiliated with the American Society of Gene & Cell Therapy. Organization details are derived from ASGCT’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction